Extracellular Vesicles and the Gartner Hype Cycle

Area of Science:

• Biotechnology and Biomedical Engineering
• Cell Biology
• Nanomedicine

Background:

• Extracellular vesicles (EVs) are increasingly recognized for their diagnostic and therapeutic potential.
• The field is currently navigating the Gartner Hype Cycle, moving from peak enthusiasm towards addressing practical challenges.

Purpose of the Study:

• To critically evaluate the current state of extracellular vesicle (EV) research using the Gartner Hype Cycle framework.
• To identify key challenges hindering the clinical translation of EV-based diagnostics and therapeutics.
• To propose actionable priorities for advancing rigorous and transparent EV research.

Main Methods:

• Analysis of the current trajectory of EV research using the Gartner Hype Cycle model.
• Identification and discussion of critical challenges in the field, such as EV heterogeneity and methodological inconsistencies.
• Review of ongoing initiatives like MISEV guidelines and the EV-TRACK database.

Main Results:

• EV research faces significant hurdles including heterogeneity, inconsistent methodologies, publication bias, and lack of standardization.
• These challenges risk impeding progress and delaying clinical translation.
• Existing initiatives (ISEV, MISEV, EV-TRACK) are crucial but require further development and adoption.

Conclusions:

• Overcoming challenges in reproducibility and standardization is essential for realizing the clinical potential of EVs.
• Implementing rigorous research practices and transparent reporting is paramount.
• A concerted effort is needed to move EV research from hype to impactful clinical application.